BACKGROUND: Stereotactic radiosurgery for the treatment of brain metastases is commonly delivered without regard to primary cancer histology. This study sought to determine if the primary site of origin for brain metastases affected the propensity for local failure. METHODS: A total of 83 patients with 200 brain metastases were examined retrospectively for predictors of infield failure. Tumor, patient, and treatment characteristics were analyzed including primary tumor histology, radiosurgical dose and age. Cox proportional hazards models, univariate and multivariate analyses were used to identify predictors of local failure. RESULTS: Freedom from local failure for the entire population was 83% and 65% at 6 and 12 months, respectively. Multivariate analysis revealed that breast cancer brain metastases have a significantly lower risk of local failure than melanoma (HR = 0.31, p< 0.001). Additionally, multivariate analysis revealed that increasing dose lowered risk for local failure (HR = 0.87, p<0.001). CONCLUSIONS: Melanoma histology leads to a higher rate of local failure. Higher prescription dose results in higher incidence of local control.
BACKGROUND: Stereotactic radiosurgery for the treatment of brain metastases is commonly delivered without regard to primary cancer histology. This study sought to determine if the primary site of origin for brain metastases affected the propensity for local failure. METHODS: A total of 83 patients with 200 brain metastases were examined retrospectively for predictors of infield failure. Tumor, patient, and treatment characteristics were analyzed including primary tumor histology, radiosurgical dose and age. Cox proportional hazards models, univariate and multivariate analyses were used to identify predictors of local failure. RESULTS: Freedom from local failure for the entire population was 83% and 65% at 6 and 12 months, respectively. Multivariate analysis revealed that breast cancer brain metastases have a significantly lower risk of local failure than melanoma (HR = 0.31, p< 0.001). Additionally, multivariate analysis revealed that increasing dose lowered risk for local failure (HR = 0.87, p<0.001). CONCLUSIONS:Melanoma histology leads to a higher rate of local failure. Higher prescription dose results in higher incidence of local control.
Authors: D Clay Cochran; Michael D Chan; Mebea Aklilu; James F Lovato; Natalie K Alphonse; J Daniel Bourland; James J Urbanic; Kevin P McMullen; Edward G Shaw; Stephen B Tatter; Thomas L Ellis Journal: J Neurosurg Date: 2012-03-02 Impact factor: 5.115
Authors: E Shaw; C Scott; L Souhami; R Dinapoli; R Kline; J Loeffler; N Farnan Journal: Int J Radiat Oncol Biol Phys Date: 2000-05-01 Impact factor: 7.038
Authors: Kirtesh R Patel; Roshan S Prabhu; Shravan Kandula; Daniel E Oliver; Sungjin Kim; Constantinos Hadjipanayis; Jeffery J Olson; Nelson Oyesiku; Walter J Curran; Mohammad K Khan; Hui-Kuo Shu; Ian Crocker Journal: J Neurooncol Date: 2014-09-05 Impact factor: 4.130
Authors: Jill S Barnholtz-Sloan; Changhong Yu; Andrew E Sloan; Jaime Vengoechea; Meihua Wang; James J Dignam; Michael A Vogelbaum; Paul W Sperduto; Minesh P Mehta; Mitchell Machtay; Michael W Kattan Journal: Neuro Oncol Date: 2012-04-27 Impact factor: 12.300
Authors: Dirk Rades; Dagmar Hornung; Oliver Blanck; Kristina Martens; Mai Trong Khoa; Ngo Thuy Trang; Michael Hüppe; Patrick Terheyden; Jan Gliemroth; Steven E Schild Journal: Strahlenther Onkol Date: 2014-03-25 Impact factor: 3.621
Authors: Ammoren E Dohm; Ryan Hughes; William Wheless; Michael Lecompte; Claire Lanier; Jimmy Ruiz; Kounosuke Watabe; Fei Xing; Jing Su; Christina Cramer; Adrian Laxton; Stephen Tatter; Michael D Chan Journal: J Neurooncol Date: 2018-10-26 Impact factor: 4.130
Authors: Hannah Johnston; Emory R McTyre; Cristina K Cramer; Glenn J Lesser; Jimmy Ruiz; J Daniel Bourland; Kounosuke Watabe; Hui-Wen Lo; Shadi Qasem; Adrian W Laxton; Stephen B Tatter; Michael D Chan Journal: J Radiosurg SBRT Date: 2017
Authors: Ryan T Hughes; Paul J Black; Brandi R Page; John T Lucas; Shadi A Qasem; Kounosuke Watabe; Jimmy Ruiz; Adrian W Laxton; Stephen B Tatter; Waldemar Debinski; Michael D Chan Journal: J Radiosurg SBRT Date: 2016
Authors: Mayur Sharma; Xuefei Jia; Manmeet Ahluwalia; Gene H Barnett; Michael A Vogelbaum; Samuel T Chao; John H Suh; Erin S Murphy; Jennifer S Yu; Lilyana Angelov; Alireza M Mohammadi Journal: Cancer Med Date: 2017-08-04 Impact factor: 4.452
Authors: Kevin Armstrong; Jennifer Ward; Mary Dunne; Luke Rock; Jennifer Westrup; Christopher R Mascott; Pierre Thirion; Alina Mihaela Mihai Journal: Front Oncol Date: 2019-05-28 Impact factor: 6.244